Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Opioids for chronic pain: molecular and genomic basis of actions and adverse effects.

Current opinion in supportive and palliative care - 1 Aug 2007

Ahmedzai Sam H, Boland Jason

Abstract excerpt

PURPOSE OF REVIEW: Opioid analgesics are being increasingly used for pain control in both cancer and noncancer patients. Despite thousands of years of their use, the biological basis of their action and adverse effects are only now being understood. It is important to understand these agents better so that the potentially large sections of the population who may eventually be eligible to receive therapeutic...

Topics

Join the communities discussing this publication.

Analgesics, Opioid
Chronic Disease
Killer Cells, Natural
Pain
Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Receptors, Opioid

Source

Identifiers

PMID: 18685352
DOI: 10.1097/SPC.0b013e3282f04e0c

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opioids for chronic pain: molecular and genomic basis of actions and adverse effects.PMID 18685352Read ↗

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Semantic proximity Read ↗

Pharmacogenomic considerations in the opioid management of painSemantic proximity Read ↗

Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review.Semantic proximity Read ↗

Review of Opioid Pharmacogenetics and Considerations for Pain ManagementSemantic proximity Read ↗

Pharmacogenomics of opioids and perioperative pain management.Semantic proximity Read ↗

Clinical implications of opioid pharmacogenetics.Semantic proximity Read ↗

Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl.Semantic proximity Read ↗

Pharmacogenomics and Opioid Analgesics: Clinical ImplicationsSemantic proximity Read ↗

Pain and genetics.Semantic proximity Read ↗

Pharmacogenetics of analgesic drugsSemantic proximity Read ↗

Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.Semantic proximity Read ↗

[Does genomics determine efficacy of analgesics?].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.